These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 8574829)

  • 1. Comparison of the vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1.
    Qadri F; Mohi G; Hossain J; Azim T; Khan AM; Salam MA; Sack RB; Albert MJ; Svennerholm AM
    Clin Diagn Lab Immunol; 1995 Nov; 2(6):685-8. PubMed ID: 8574829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1.
    Qadri F; Wennerås C; Albert MJ; Hossain J; Mannoor K; Begum YA; Mohi G; Salam MA; Sack RB; Svennerholm AM
    Infect Immun; 1997 Sep; 65(9):3571-6. PubMed ID: 9284121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vibriocidal antibody responses in North American volunteers exposed to wild-type or vaccine Vibrio cholerae O139: specificity and relevance to immunity.
    Losonsky GA; Lim Y; Motamedi P; Comstock LE; Johnson JA; Morris JG; Tacket CO; Kaper JB; Levine MM
    Clin Diagn Lab Immunol; 1997 May; 4(3):264-9. PubMed ID: 9144361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
    Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
    Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of O-specific polysaccharide responses in patients following infection with
    Kaisar MH; Kelly M; Kamruzzaman M; Bhuiyan TR; Chowdhury F; Khan AI; LaRocque RC; Calderwood SB; Harris JB; Charles RC; Čížová A; Mečárová J; Korcová J; Bystrický S; Kováč P; Xu P; Qadri F; Ryan ET
    mSphere; 2023 Oct; 8(5):e0025523. PubMed ID: 37646517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum antibacterial and antitoxin responses in clinical cholera caused by Vibrio cholerae O139 Bengal and evaluation of their importance in protection.
    Nandy RK; Albert MJ; Ghose AC
    Vaccine; 1996 Aug; 14(12):1137-42. PubMed ID: 8911010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining Polysaccharide-Specific Antibody Targets against Vibrio cholerae O139 in Humans following O139 Cholera and following Vaccination with a Commercial Bivalent Oral Cholera Vaccine, and Evaluation of Conjugate Vaccines Targeting O139.
    Kamruzzaman M; Kelly M; Charles RC; Harris JB; Calderwood SB; Akter A; Biswas R; Kaisar MH; Bhuiyan TR; Ivers LC; Ternier R; Jerome JG; Pfister HB; Lu X; Soliman SE; Ruttens B; Saksena R; Mečárová J; Čížová A; Qadri F; Bystrický S; Kováč P; Xu P; Ryan ET
    mSphere; 2021 Aug; 6(4):e0011421. PubMed ID: 34232076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgM specific to lipopolysaccharide of Vibrio cholerae is a surrogate antibody isotype responsible for serum vibriocidal activity.
    Yang JS; An SJ; Jang MS; Song M; Han SH
    PLoS One; 2019; 14(3):e0213507. PubMed ID: 30845262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in capsular content and enhanced bacterial susceptibility to serum killing of Vibrio cholerae O139 associated with the 2002 cholera epidemic in Bangladesh.
    Qadri F; Svennerholm AM; Shamsuzzaman S; Bhuiyan TR; Harris JB; Ghosh AN; Nair GB; Weintraub A; Faruque SM; Ryan ET; Sack DA; Calderwood SB
    Infect Immun; 2005 Oct; 73(10):6577-83. PubMed ID: 16177333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vibrio cholerae O139 conjugate vaccines: synthesis and immunogenicity of V. cholerae O139 capsular polysaccharide conjugates with recombinant diphtheria toxin mutant in mice.
    Kossaczka Z; Shiloach J; Johnson V; Taylor DN; Finkelstein RA; Robbins JB; Szu SC
    Infect Immun; 2000 Sep; 68(9):5037-43. PubMed ID: 10948122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation and characterization of a human volunteer challenge model for cholera by using frozen bacteria of the new Vibrio cholerae epidemic serotype, O139.
    Cohen MB; Giannella RA; Losonsky GA; Lang DR; Parker S; Hawkins JA; Gunther C; Schiff GA
    Infect Immun; 1999 Dec; 67(12):6346-9. PubMed ID: 10569748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology & molecular biology of Vibrio cholerae O139 Bengal.
    Albert MJ
    Indian J Med Res; 1996 Jul; 104():14-27. PubMed ID: 8783504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophoretic mobility and immune response of outer membrane proteins of Vibrio cholerae O139.
    Pal S; Sasmal D; Guhathakurta B; Nair GB; Bhattacharya SK; Mallick R; Datta A
    FEMS Immunol Med Microbiol; 1996 Sep; 15(2-3):143-8. PubMed ID: 8880140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and immunologic characteristics of Vibrio cholerae O139 Bengal infection in North American volunteers.
    Morris JG; Losonsky GE; Johnson JA; Tacket CO; Nataro JP; Panigrahi P; Levin MM
    J Infect Dis; 1995 Apr; 171(4):903-8. PubMed ID: 7706818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and Genetic Variation of Vibrio cholerae Isolated from Clinical and Environmental Sources in Thailand.
    Siriphap A; Leekitcharoenphon P; Kaas RS; Theethakaew C; Aarestrup FM; Sutheinkul O; Hendriksen RS
    PLoS One; 2017; 12(1):e0169324. PubMed ID: 28103259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vibrio cholerae O1 vibriocidal and anti-cholera toxin antibodies in O139 Bengal cholera patients.
    Takeda T; Ramamurthy T; Chowdhury AS; Dutta D; Bhattacharya SK; Deb BC; Nair GB; Takeda Y
    J Infect; 1994 Sep; 29(2):233-5. PubMed ID: 7806891
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune response to the mannose-sensitive hemagglutinin in patients with cholera due to Vibrio cholerae O1 and O0139.
    Qadri F; Jonson G; Begum YA; Wennerås C; Albert MJ; Salam MA; Svennerholm AM
    Clin Diagn Lab Immunol; 1997 Jul; 4(4):429-34. PubMed ID: 9220159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh.
    Saha D; LaRocque RC; Khan AI; Harris JB; Begum YA; Akramuzzaman SM; Faruque AS; Ryan ET; Qadri F; Calderwood SB
    J Infect Dis; 2004 Jun; 189(12):2318-22. PubMed ID: 15181581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiologic study of Vibrio cholerae O1 and O139 in Thailand: at the advancing edge of the eighth pandemic.
    Hoge CW; Bodhidatta L; Echeverria P; Deesuwan M; Kitporka P
    Am J Epidemiol; 1996 Feb; 143(3):263-8. PubMed ID: 8561160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of immune responses to the O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi adult patients with cholera.
    Johnson RA; Uddin T; Aktar A; Mohasin M; Alam MM; Chowdhury F; Harris JB; LaRocque RC; Bufano MK; Yu Y; Wu-Freeman Y; Leung DT; Sarracino D; Krastins B; Charles RC; Xu P; Kovác P; Calderwood SB; Qadri F; Ryan ET
    Clin Vaccine Immunol; 2012 Nov; 19(11):1712-21. PubMed ID: 22993410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.